Resistant Hypertension Optimal Treatment

NCT01643434 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Spironolactone
DRUG: Clonidine

Sponsor

Instituto do Coracao

Collaborators

[object Object]